The government of Hong Kong has just announced that effective Wednesday, December 14th 2022, almost all restrictions for international travelers will be removed, which includes restrictions on movement and the issuance of the Amber (probation-like) health code via app.

The Hurun Research Institute today, in association with Jiaxing City in East China, released the 2022 Hurun Global 500, a list of the 500 most valuable non-state-controlled companies in the world.

Immune cell gene expression patterns and subtypes may hold clues to immune-related adverse effects (AEs) that cancer patients develop after immune checkpoint blockade immunotherapy (ICI), new research suggests.

Swiss firm 4D Lifetec said Monday it has forged a partnership with the Molecular Diagnostics Group to produce and automate 4D Lifetec's cancer assays and develop the tests for high-throughput screening.

The data shows that the current average daily sales volume of self-test boxes has increased by more than 400 times compared with November.

Tesis Biosciences wants to pinpoint biomarkers to better diagnose mild traumatic brain injury, the genetic sequencing company said Friday.

A team has identified cell type-specific gene expression signatures in blood samples from individuals with acute SARS-CoV-2 infections that appeared to predict the risk and types of long-term symptoms they may experience

Roche announced on Thursday that two of its tests for Alzheimer's disease have received 510(k) clearance from the US Food and Drug Administration.

The US Food and Drug Administration this week granted Emergency Use Authorization to Diazyme Laboratories for a SARS-CoV-2 total antibody test.

After evaluation by the American Chemical Society (ACS) and INSPEC, the English scientific journal VIEW, PCEM and WILEY, has been evaluated by Content Selection & Advisory Board，CSAB and officially Indexed in Scopus.

Editor's note: Major adjustments have been made to China's COVID-19 control policies, according to a 10-point notice released by the National Health Commission on Wednesday. Below are some of the key changes, to help you keep up to date.

Thermo Fisher Scientific said on Wednesday that its SeCore CDx HLA Sequencing System was granted de novo classification by the US Food and Drug Administration as a companion diagnostic to Immunocore’s Kimmtrak (tebentafusp-tebn) therapy for uveal melanoma.

Scientists from the National University of Singapore (NUS) have discovered a novel low-cost method of testing for cancers. Called the Heatrich-BS assay, this new test sequences clinical samples that have been heated in order to isolate cancer-specific signatures found in a patient’s blood.

The European Commission has issued a Statement of Objections to Illumina and Grail on Monday, outlining the restorative measures it intends to adopt under the EU Merger Regulation.

Leica Biosystems has acquired Cell IDx, Inc., a leader in multiplexed tissue profiling. Founded in 2012 and headquartered in San Diego, California, Cell IDx provides multiplex staining panels, tissue staining, and imaging and analysis services.